Barry Bunin

Barry Bunin is the CEO and President of Collaborative Drug Discovery (CDD, Inc.), a company he founded in 2004 as a spin-out from Eli Lilly. He holds a PhD and has been instrumental in developing CDD's web-based database solutions for managing drug discovery data, particularly through their flagship product, CDD Vault. This platform facilitates collaboration among researchers by providing tools for chemical registration, assay data management, and structure-activity relationship (SAR) analysis.12

Under Bunin's leadership, CDD has expanded its offerings, including the launch of PharmaKB in 2021, which serves as a comprehensive knowledge base for pharmaceutical data.1 His vision has attracted significant collaborations, including a notable grant from the Bill & Melinda Gates Foundation to support tuberculosis research.1

Bunin's work emphasizes innovation in drug discovery processes, making CDD a key player in the field of cheminformatics and research informatics.12